Skip to main navigation Skip to search Skip to main content

Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: Results of a randomized, double-blind, placebo- and active-controlled phase 2 trial

  • David Calhoun
  • , William White
  • , Henry Krum
  • , Weinong Guo
  • , Georgina Bermann
  • , Angelo Trapani
  • , Martin Lefkowitz
  • , Joel Menard

Research output: Contribution to journalArticleResearchpeer-review

Abstract

LCI699, a novel inhibitor of aldosterone synthase, reduces serum aldosterone, and may have benefit in the treatment of hypertension.
Original languageEnglish
Pages (from-to)1945 - 1955
Number of pages11
JournalCirculation
Volume124
Issue number18
DOIs
Publication statusPublished - 2011

Cite this